Report cover image

Europe Cat Vaccine Market Size, Share & Trends Analysis Report By Component, By Route of Administration (Injectables, Intranasal, and Oral), By Duration of Immunity, By Disease Type, By Type, By Country and Growth Forecast, 2024 - 2031

Publisher Knowledge Based Value (KBV) Research
Published Jul 12, 2024
Length 136 Pages
SKU # KBV19028704

Description

Europe Cat Vaccine Market Size, Share & Trends Analysis Report By Component, By Route of Administration (Injectables, Intranasal, and Oral), By Duration of Immunity, By Disease Type, By Type, By Country and Growth Forecast, 2024 - 2031


The Europe Cat Vaccine Market would witness market growth of 8.9% CAGR during the forecast period (2024-2031).

The Germany market dominated the Europe Cat Vaccine Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $166 million by 2031. The UK market is exhibiting a CAGR of 7.9% during (2024 - 2031). Additionally, The France market would experience a CAGR of 10.1% during (2024 - 2031).

Organizations like the American Veterinary Medical Association (AVMA) have been instrumental in promoting pet health awareness in the United States. The AVMA runs numerous campaigns highlighting the importance of vaccinations in preventing diseases such as rabies, feline leukemia virus (FeLV), and feline immunodeficiency virus (FIV). In Europe, similar initiatives are seen through the efforts of the Federation of Veterinarians of Europe (FVE). The FVE works closely with national veterinary associations to raise awareness about pet health and vaccinations.

For example, in the United Kingdom, the British Veterinary Association (BVA) collaborates with local veterinarians to run vaccination awareness campaigns. These campaigns include Pet Health Weeks, during which clinics offer discounted vaccination services and educational workshops for pet owners. Such initiatives have significantly increased public awareness about the importance of vaccinating pets and have increased vaccination rates.

In Germany, the rising demand for cat vaccines is largely attributed to the country's comprehensive pet health regulations and high pet ownership rates. The German Pet Trade & Industry Association (ZZF) reports about 15.7 million cats in German households. German regulations require vaccinations for cats, particularly against rabies, which is mandatory for cats traveling within the European Union. The Federal Ministry of Food and Agriculture (BMEL) supports vaccination programs and campaigns that promote responsible pet ownership and preventive healthcare. Additionally, German veterinary practices are well-integrated with national and EU-wide health initiatives, providing consistent and accessible vaccination services. Thus, the European cat vaccine market presents a promising picture.

Based on Component, the market is segmented into Combined Vaccines, and Mono Vaccines. Based on Route of Administration, the market is segmented into Injectables, Intranasal, and Oral. Based on Duration of Immunity, the market is segmented into 1 Year, 3 Year, and Others. Based on Disease Type, the market is segmented into Feline Respiratory Diseases, Feline Rabies, Feline Panleukopenia (Feline Distemper), Feline Leukemia, and Others. Based on Type, the market is segmented into Modified/Attenuated Live, Inactivated (Killed), and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

List of Key Companies Profiled
  • Zoetis, Inc.
  • Elanco Animal Health, Inc.
  • Merck & Co., Inc.
  • Boehringer Ingelheim International GmbH
  • Covetrus, Inc. (Clayton, Dubilier & Rice, LLC)
  • Virbac
  • Heska Corporation (Antech Diagnostics, Inc)
  • Ceva Sante Animale
  • Bioveta, a.s.
Europe Cat Vaccine Market Report Segmentation

By Component
  • Combined Vaccines
  • Mono Vaccines
By Route of Administration
  • Injectables
  • Intranasal
  • Oral
By Duration of Immunity
  • 1 Year
  • 3 Year
  • Others
By Disease Type
  • Feline Respiratory Diseases
  • Feline Rabies
  • Feline Panleukopenia (Feline Distemper)
  • Feline Leukemia
  • Others
By Type
  • Modified/Attenuated Live
  • Inactivated (Killed)
  • Others
By Country
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe

Table of Contents

136 Pages
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Cat Vaccine Market, by Component
1.4.2 Europe Cat Vaccine Market, by Route of Administration
1.4.3 Europe Cat Vaccine Market, by Duration of Immunity
1.4.4 Europe Cat Vaccine Market, by Disease Type
1.4.5 Europe Cat Vaccine Market, by Type
1.4.6 Europe Cat Vaccine Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter Five Forces Analysis
Chapter 4. Strategies Deployed in Cat Vaccine Market
Chapter 5. Europe Cat Vaccine Market by Component
5.1 Europe Combined Vaccines Market by Country
5.2 Europe Mono Vaccines Market by Country
Chapter 6. Europe Cat Vaccine Market by Route of Administration
6.1 Europe Injectables Market by Country
6.2 Europe Intranasal Market by Country
6.3 Europe Oral Market by Country
Chapter 7. Europe Cat Vaccine Market by Duration of Immunity
7.1 Europe 1 Year Market by Country
7.2 Europe 3 Year Market by Country
7.3 Europe Others Market by Country
Chapter 8. Europe Cat Vaccine Market by Disease Type
8.1 Europe Feline Respiratory Diseases Market by Country
8.2 Europe Feline Rabies Market by Country
8.3 Europe Feline Panleukopenia (Feline Distemper) Market by Country
8.4 Europe Feline Leukemia Market by Country
8.5 Europe Others Market by Country
Chapter 9. Europe Cat Vaccine Market by Type
9.1 Europe Modified/Attenuated Live Market by Country
9.2 Europe Inactivated (Killed) Market by Country
9.3 Europe Others Market by Country
Chapter 10. Europe Cat Vaccine Market by Country
10.1 Germany Cat Vaccine Market
10.1.1 Germany Cat Vaccine Market by Component
10.1.2 Germany Cat Vaccine Market by Route of Administration
10.1.3 Germany Cat Vaccine Market by Duration of Immunity
10.1.4 Germany Cat Vaccine Market by Disease Type
10.1.5 Germany Cat Vaccine Market by Type
10.2 UK Cat Vaccine Market
10.2.1 UK Cat Vaccine Market by Component
10.2.2 UK Cat Vaccine Market by Route of Administration
10.2.3 UK Cat Vaccine Market by Duration of Immunity
10.2.4 UK Cat Vaccine Market by Disease Type
10.2.5 UK Cat Vaccine Market by Type
10.3 France Cat Vaccine Market
10.3.1 France Cat Vaccine Market by Component
10.3.2 France Cat Vaccine Market by Route of Administration
10.3.3 France Cat Vaccine Market by Duration of Immunity
10.3.4 France Cat Vaccine Market by Disease Type
10.3.5 France Cat Vaccine Market by Type
10.4 Russia Cat Vaccine Market
10.4.1 Russia Cat Vaccine Market by Component
10.4.2 Russia Cat Vaccine Market by Route of Administration
10.4.3 Russia Cat Vaccine Market by Duration of Immunity
10.4.4 Russia Cat Vaccine Market by Disease Type
10.4.5 Russia Cat Vaccine Market by Type
10.5 Spain Cat Vaccine Market
10.5.1 Spain Cat Vaccine Market by Component
10.5.2 Spain Cat Vaccine Market by Route of Administration
10.5.3 Spain Cat Vaccine Market by Duration of Immunity
10.5.4 Spain Cat Vaccine Market by Disease Type
10.5.5 Spain Cat Vaccine Market by Type
10.6 Italy Cat Vaccine Market
10.6.1 Italy Cat Vaccine Market by Component
10.6.2 Italy Cat Vaccine Market by Route of Administration
10.6.3 Italy Cat Vaccine Market by Duration of Immunity
10.6.4 Italy Cat Vaccine Market by Disease Type
10.6.5 Italy Cat Vaccine Market by Type
10.7 Rest of Europe Cat Vaccine Market
10.7.1 Rest of Europe Cat Vaccine Market by Component
10.7.2 Rest of Europe Cat Vaccine Market by Route of Administration
10.7.3 Rest of Europe Cat Vaccine Market by Duration of Immunity
10.7.4 Rest of Europe Cat Vaccine Market by Disease Type
10.7.5 Rest of Europe Cat Vaccine Market by Type
Chapter 11. Company Profiles
11.1 Zoetis, Inc.
11.1.1 Company Overview
11.1.2 Financial Analysis
11.1.3 Regional Analysis
11.1.4 Research & Development Expenses
11.1.5 Recent strategies and developments:
11.1.5.1 Partnerships, Collaborations, and Agreements:
11.1.5.2 Product Launches and Product Expansions:
11.1.5.3 Acquisition and Mergers:
11.1.6 SWOT Analysis
11.2 Elanco Animal Health, Inc.
11.2.1 Company Overview
11.2.2 Financial Analysis
11.2.3 Regional Analysis
11.2.4 Research & Development Expenses
11.2.5 SWOT Analysis
11.3 Merck & Co., Inc.
11.3.1 Company Overview
11.3.2 Financial Analysis
11.3.3 Segmental and Regional Analysis
11.3.4 Research & Development Expenses
11.3.5 SWOT Analysis
11.4 Boehringer Ingelheim International GmbH
11.4.1 Company Overview
11.4.2 Financial Analysis
11.4.3 Regional & Segmental Analysis
11.4.4 Research & Development Expenses
11.4.5 Recent strategies and developments:
11.4.5.1 Trials and Approvals:
11.4.6 SWOT Analysis
11.5 Covetrus, Inc. (Clayton, Dubilier & Rice, LLC)
11.5.1 Company Overview
11.5.2 SWOT Analysis
11.6 Virbac
11.6.1 Company Overview
11.6.2 Financial Analysis
11.6.3 Regional Analysis
11.6.4 Recent strategies and developments:
11.6.4.1 Acquisition and Mergers:
11.6.5 SWOT Analysis
11.7 Heska Corporation (Antech Diagnostics, Inc)
11.7.1 Company Overview
11.7.2 SWOT Analysis
11.8 Ceva Sante Animale
11.8.1 Company Overview
11.8.2 SWOT Analysis
11.9 Bioveta, a.s.
11.9.1 Company Overview

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us